Novo Nordisk Owner to Plow Obesity Drug Profit Into Green Market

The shareholder that controls Novo Nordisk A/S is responding to a downturn in green assets by ratcheting up investments with profits from the obesity drugmaker. #press

https://www.bloomberg.com/news/articles/2023-09-14/novo-nordisk-owner-to-plow-obesity-drug-profit-into-green-market?utm_source=press.coop

Reply to this note

Please Login to reply.

Discussion

No replies yet.